This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Type of economic evaluation
Cost-effectiveness analysis
Study objective
The objective was to examine the clinical and economic impact of chlorhexidine compared with iodine for preoperative skin antisepsis in surgical patients for the prevention of surgical-site infections.
Interventions
Two preparations of chlorhexidine were considered: a 113g bottle of 4% chlorhexidine and single-use applicators of a 2% chlorhexidine gluconate and 70% isopropyl alcohol solution. The comparator was a 118mL 7.5% povidone-iodine surgical scrub.
Location/setting
USA/hospital.
Methods

Analytical approach:
The analysis was based on a decision-analytic model. The authors stated that the perspective of the hospital was adopted.
Effectiveness data:
A literature review was undertaken by searching the website of the Agency for Healthcare Research and Quality (AHRQ) and electronic databases, such as the Cochrane Library, MEDLINE, and EMBASE for systematic reviews, meta-analyses, or randomised controlled trials (RCTs) on the two interventions. The inclusion and exclusion criteria were reported and nine RCTs were found. Heterogeneity between these trials and the quality of their evidence were considered and a fixed-effect meta-analysis was used to synthesise the clinical endpoints. The rate of surgical-site infection and the rate of positive skin culture after application were the key inputs for the model.
Monetary benefit and utility valuations:
Not considered.
Measure of benefit:
The rate of surgical-site infection and rate of positive skin culture after application were the outcomes of the clinical analysis.
Cost data:
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